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Summary
 
Each member of the rab guanosine triphosphatase protein family assists in the regulation of a
specific step within the biosynthetic or endocytic pathways. We have found that the early en-
dosome-associated rab4 protein controls a step critical for receptor-mediated antigen processing
in a murine A20 B cell line. Expression of the dominant negative rab4N
 
121
 
I mutant dramati-
cally inhibited the processing and presentation of ovalbumin, 
 
l
 
 cI repressor, or rabbit immuno-
globulin G internalized as antigens by B cell antigen receptors or transfected Fc receptors. This
defect did not reflect a block in antigen endocytosis or degradation, and transfected cells re-
mained completely capable of presenting exogenously added ovalbumin and 
 
l
 
 repressor pep-
tides. Most remarkably, rab4N
 
121
 
I-expressing cells were undiminished in their ability to present
each of these antigens when whole proteins were internalized at high concentration by fluid-
phase endocytosis. Thus, expression of the rab4N
 
121
 
I selectively inactivated a portion of the en-
docytic pathway required for the processing of receptor-bound, but not nonspecifically inter-
nalized, antigens. These results suggest that elements of the early endosome-recycling pathway
play an important and selective role in physiologically relevant forms of antigen processing in B
cells.
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P
 
resentation of immunogenic peptides bound to MHC
class II molecules to CD4
 
1
 
 T cells typically involves
the endocytosis of exogenous Ag. Internalized Ags are pro-
teolyzed and the resulting peptides are loaded onto MHC
class II 
 
a/b
 
 dimers, either newly synthesized or internalized
from the plasma membrane (1–3). Although these events
can occur in most cell types, professional APCs have a
number of specializations that contribute to their Ag pro-
cessing efficiency. For example, B cells express Ag recep-
tors that bind and internalize only that Ag for which an indi-
vidual B cell receptor (BCR)
 
1
 
 is specific (2, 4–6). Endocytosis
via the BCR not only greatly increases the sensitivity of
processing but also helps ensure that B cells stimulate only
T cells that are specific for the processed Ag (2, 4–9).
BCR–Ag complexes first enter early endosomes via
clathrin-coated vesicles. A fraction of these complexes re-
turn, within recycling endosomes, to the surface, while an-
other fraction is targeted to late endosomes and lysosomes
where the majority of Ag is degraded to amino acids (8, 9).
MHC class II molecules are contained throughout these
endocytic compartments in varying quantities. This broad
distribution of class II and associated molecules suggests that
peptide–class II complexes can be formed at multiple sites,
collectively termed MIIC (MHC-containing compartments;
1–3). However, intracellular accumulation of immunogenic
complexes may not reflect physiologically relevant sites of
Ag processing or peptide loading. For example, immature
dendritic cells form peptide–class II complexes in late endo-
somes or lysosomes, but few of these complexes are re-
cruited to the plasma membrane (3). A related issue is
whether APCs contain specialized compartments for Ag
processing. Cell fractionation has revealed the existence of
distinct endosome-related class II vesicles that may serve
this function (9, 10).
To dissect the relative contributions of various endocytic
compartments to Ag processing, we have used a novel
strategy using rab proteins. Monomeric GTPases of the rab
protein family have proven useful as tools for studying the
functions of vesicular traffic in a variety of cell types (12).
Rabs are believed to assist in the assembly of large protein
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; DNP, dinitrophenyl;
HRP, horseradish peroxidase; TfnR, transferrin receptor; WT, wild-type.
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complexes needed for vesicle–vesicle fusion (12). Since ev-
ery family member has a characteristic organelle distribu-
tion, expression of mutant rab proteins can selectively tar-
get individual membrane transport steps (12–15). For the
early endocytic pathway, rab5 appears to regulate entry of
incoming clathrin-coated vesicles into early endosomes,
whereas rab4 and rab11 assist in later steps of receptor recy-
cling (13–15). By expressing a dominant-negative mutant
of rab4, we demonstrate a critical role for early endocytic
compartments in receptor-mediated, but not nonspecific,
Ag processing.
 
Materials and Methods
 
Establishment of Stable Transfectants.
 
 A6B9 is a stable cell line
derived from the IIA1.6 B cell lymphoma, a cell that lacks endog-
enous FcR
 
g
 
RII-B1 expression, transfected with a pCB6 expression
vector (G418-resistance) containing the cDNA for FcR
 
g
 
RII-B2
(16). For expression of rab4, A6B9 cells were electroporated
(Bio-Rad Gene Pulser, 300 volts and 960 
 
m
 
F; Bio-Rad, Her-
cules, CA) with the plasmid pMCFRpac (puromycin resistance)
containing an EcoRI fragment derived from the human rab4a
cDNA (15). The pMCFR vector, provided by Tom Novack and
Lisa Denzin (Yale University, New Haven, CT), provides high
expression levels in lymphocytes (17). The wild-type (WT) rab4
was tagged for Ab detection with an epitope from influenza virus
(HA) to distinguish the transfected from endogenous proteins.
Epitope tagging has been shown to affect neither the localization
nor function of rab4 (17). Drug-resistant cells were screened ini-
tially for rab4 expression by Western blotting. Expression was
verified routinely by flow cytometry (FcR
 
g
 
RII-B2) or immuno-
fluorescence microscopy and Western blotting (rab4). Clonal
populations were maintained as stable lines for these studies; typi-
cally 80–90% of each cell line coexpressed the transfected genes.
Cells were grown in IMDM with 10% FCS, 50 
 
m
 
M 
 
b
 
-mercapto-
ethanol, 600 
 
m
 
g/ml geneticin (GIBCO BRL, Gaithersburg,
MD), and 2.5 
 
m
 
g/ml puromycin (Sigma Chemical Co., St. Louis,
MO) with 5% CO
 
2
 
 at 37
 
8
 
C.
 
Western Blotting.
 
Cell pellets were lysed in 0.5% Triton X-100
detergent and clarified. Protein was quantitated with the Bio-Rad
protein assay and normalized. Laemmli buffer–solubilized cell
lysates (10 
 
m
 
g) were run on 14% polyacrylamide SDS-gels and
transferred to nitrocellulose using a carbonate buffer system as
previously described (15). Western blot analysis using rabbit serum
specific for a peptide sequence derived from the COOH-tail of
rab4 (8091) or a glutathione 
 
S
 
-transferase–modified rab4 protein
and chemiluminescent detection (Pierce Chemical Co., Rockford,
IL) was followed by densitometric scanning of the fluorographs.
 
Flow Cytometry.
 
After washing in PBS without Ca
 
2
 
1
 
 or
Mg
 
2
 
1
 
,
 
 
 
cells were incubated with fluorescent Abs (1 
 
m
 
g Ab/10
 
6
 
cells; PharMingen, San Diego, CA) in PBS with 2% BSA, 0.5%
sodium azide on ice for 1 h. After labeling, cells were washed and
fixed in 1% paraformaldehyde for flow analysis. Nonspecific
binding was determined using purified rat IgG, isotype-specific
Abs, or secondary Ab alone; nonspecific binding to the FcR was
blocked with 2.4G2. A FACSVantage
 
Ò
 
 (Becton Dickinson, San
Jose, CA) was used to visualize cell surface fluorescent labeling.
Data analysis was performed using CellQuest software (Becton
Dickinson). MKD6-PE was a generous gift from Marilyn Kehrey
at Boehringer Ingelheim Pharmaceuticals, Inc.
 
Confocal Microscopy.
 
Log phase B cells were harvested,
washed with PBS
 
2
 
1
 
, and then allowed to settle on Alcian blue-
coated coverslips. Cells were fixed in 3.5% paraformaldehyde in
PBS, quenched with 20 mM glycine, and blocked/permeabilized
in IMDM containing 10% FCS, 10 mM Hepes, pH 7.4, and
0.02% saponin. Primary Abs used to visualize each marker were
as follows: for rab4, an affinity purified polyclonal 8091; for lgpA,
supernatants of the GL2A7 mAb; for MHC class II, the M5114
mAb; and for transferrin receptor (TfnR), the TIB219 mAb. Op-
tical sections (0.2 
 
m
 
m) were viewed using a microscope (MRC
650; Bio-Rad) with an 
 
3
 
63 objective and a magnification of 1.5.
 
Endocytosis and Degradation.  
 
Endocytosis assays were per-
formed as previously detailed (17, 18). In brief, cells were incu-
bated with Ags (10
 
7
 
 cells/ml) for 1 h at 0
 
8
 
C. After multiple
washes, cells were warmed to 37
 
8
 
C for various chase times,
cooled again and the cell- and media-associated Ags were quanti-
fied by assaying the horseradish peroxidase (HRP) activity in the
presence of Triton X-100. In all cases, immune complexes were
formed by incubating (30 min at 37
 
8
 
C) affinity pure anti-dinitro-
phenyl (DNP) polyclonal serum with DNP-modified chicken
OVA (DNP-OVA). In all experiments immune complexes were
composed of Ab–Ag complexes with a molar ratio of 2.5:1, re-
spectively. HRP was assayed using 
 
o
 
-phenylenediamine dihydro-
chloride (Sigma Chemical Co.) as substrate. DNP-modifications
of OVA, HRP, and BSA were as previously described (17).
DNP-BSA was iodinated as previously described (18).
 
Ag Presentation.
 
Presentation assays comprised an incubation
of B cells (10
 
5
 
 cells/well), T cell hybridomas (10
 
5
 
 cells/well), and
varying concentrations of Ag in 96-well dishes at 37
 
8
 
C with 5%
CO
 
2
 
 overnight. Supernatants were assayed for the presence of IL-2
using either a [
 
3
 
H]thymidine proliferation assay with an IL-2–
dependent CTLL-2 cell line (42, 50) or an IL-2 ELISA (Phar-
Mingen). The 2R.50 T cell hybridoma was a gift from Rick
Mitchell (Harvard Medical School, Cambridge, MA) (4, 11);
DO-11.10 T cell hybridoma was provided by Philippa Marrack
(Colorado University, Denver, CO) (19). In the case of presenta-
tion using fixed APCs, B cells were fed Ag for 3–4 h, fixed in
0.5% paraformaldehyde at room temperature for 20–30 min, and
washed extensively with 20 mM glycine before incubation with T
cell hybridomas (4).
 
Results
 
Production of B Cell Lines Expressing WT and Mutant rab4.
 
For A20 B cells, membrane fractionation studies suggest
that only early endosomal compartments are required for
BCR-dependent processing (9–11), consistent with obser-
vations that relatively little class II accumulates at later
endocytic sites (17). To study the role of rab4 and the re-
cycling pathway in B cell presentation, we produced sta-
ble transfectants of mouse B cells overexpressing either a
WT rab4 protein or a dominant negative mutant form,
rab4N
 
121
 
I, which contains an asparagine to isoleucine point
mutation known to inhibit nucleotide binding (15). Stable
cell lines were produced using A6B9, a derivative of A20
cells transfected with an internalization-competent isoform
of the mouse macrophage Fc receptor II (Fc
 
g
 
RII-B2), thus
allowing for endocytic uptake of antigenic immune com-
plexes (16). WT rab4 and rab4N
 
121
 
I were expressed at lev-
els 20- and 8-fold, respectively, above the endogenous pro-
tein levels (Fig. 1 
 
A
 
).
We first analyzed the cell surface expression of several
membrane proteins involved in Ag presentation. Flow cy- 
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tometry showed that both of the MHC class II alleles, I-A
 
d
 
and I-E
 
d
 
, were unaffected (Fig. 1 
 
B
 
) by overexpression of
either WT rab4 or rab4N
 
121
 
I. In pulse–chase studies, we
saw no effect on the synthesis of MHC class II molecules or
formation of SDS stable 
 
a/b
 
 dimers (20 and data not
shown), suggesting that peptide loading of some Ags was
normal in the stable lines. Additionally, the levels of surface
expression of both BCR and FcRII
 
g
 
-B2 were similar in all
transfectants (Fig. 1 
 
B
 
). Thus, overexpression of either WT
or mutant rab4 had no major effect on the surface expres-
sion of several functional membrane proteins.
We next determined the intracellular distribution of
several different endosomal markers relative to that of WT or
mutant rab4 using confocal microscopy. Immunofluorescent
labeling of saponin-permeabilized cells for MHC class II,
lgp-A/lamp-1, and TfnR showed no dramatic differences
between the control, WT, and rab4N
 
121
 
I cells as found in
other cell types (15, 21). Rab4 itself appeared as small punc-
tate structures whose labeling showed partial overlap with
Tfn, a recycling endosomal marker (15, 21). As expected,
neither the WT nor mutant rab4s colocalize with lgp-A, in-
dicating that their distribution did not include late endosomes
or lysosomes (Fig. 2 
 
B
 
). Only a minor degree of colocaliza-
tion between rab4 and MHC class II molecules was observed.
 
Expression of Mutant rab4 Does Not Affect Ag Uptake and
Degradation.
 
Identifying which elements of the endocytic
pathway are most important in BCR-mediated Ag process-
ing has proved a vexing problem. There is evidence that
different compartments are involved, depending upon the
type of Ag or epitope; however, many of these studies have
relied upon Ag delivery via nonspecific fluid phase endocy-
tosis (1–3). To address this issue we studied the ability of
these stable lines to process receptor-bound Ags. We first
monitored the ability of the rab4-transfected cells to inter-
nalize and degrade different Ags. To measure BCR-medi-
ated endocytosis, the HRP-conjugated rabbit F(ab
 
9
 
)
 
2
 
 anti–
mouse Ab was bound to the cell surface in the cold, as Ag,
then followed into the cells upon warming by measuring
the total versus surface HRP activity. To measure endocy-
tosis of Ag–Ab complexes via transfected Fc
 
g
 
RII-B2, the
same assays were conducted except using immune com-
plexes composed of HRP and anti-HRP IgG. Expression
of either WT rab4 or rab4N
 
121
 
I did not significantly alter
the rates of internalization of BCR-bound F(ab
 
9
 
)
 
2
 
 frag-
ments relative to mock-transfected control cells (Fig. 3 
 
A
 
).
Similar results were obtained for FcR-bound immune
complexes (Fig. 3 
 
B
 
).
Internalized Ag also appeared to be degraded at normal
rates as determined by measuring the release of TCA-solu-
Figure 1. Overexpression of
HA-tagged WT rab4 or domi-
nant negative rab4N121I did not
affect MHC class II expression.
(A) Western blots representing
cell lysates derived from stable
cell lines expressing control (vec-
tor alone), WT, and rab4N121I
are shown. The predominant
protein  that reacted with rab4-
specific antisera corresponded to a
MW of z34 kD. Note the
slower mobility of the WT pro-
tein as expected due to the HA-
tag. The lowest molecular
weight band could be eliminated
by including protease inhibitors
in the lysis buffer. (B) Flow cyto-
metric scans of cells labeled for I-Ad (MKD6-PE); I-Ed (14-4-4S-FITC);
FcR (2.4G2 and an FITC-labeled goat anti–rat IgG Fab fragment); or
membrane IgG (rabbit anti-IgG2a and FITC-goat F(ab9)2 anti–rabbit
IgG). Each graph represents the overlay of traces from control (thin line),
WT (thick line) and rab4N121I (dotted line) cell lines and includes an overlay
of the nonspecific binding.
Figure 2. WT and mutant rab4 are restricted to early endocytic com-
partments in transfected A20 B cells. Scanning laser confocal micrographs
show the intracellular distributions of WT and rab4N121I relative to TfnR
(A), the lysosomal membrane glycoprotein lgpB/lamp-2 (B), and MHC
class II (I-Ad, C).
Figure 3. Expression of WT
and rab4N121I had no effect on
receptor-mediated Ag endocyto-
sis and degradation. (A) Endo-
cytosis of rabbit F(ab9)2 anti–
mouse IgG by BCR. A20 cells
were incubated with HRP-rabbit
F(ab9)2 anti–mouse IgG (50 mg/
ml) in the cold for 1 h, washed,
and then rapidly warmed to 378C
for 0–45 min. Surface versus total
F(ab9)2 fragments were defined as
the HRP activity in the absence
or presence of Triton X-100, re-
spectively (47). The percentage
of intracellular ligand was esti-
mated by subtraction from the
total and plotted against time of
uptake. (B) Internalization and
degradation of Fc receptor-bound Ag. FcR-mediated endocytosis was de-
termined using HRP–rabbit anti-HRP immune complexes similar to the
assay described in A. Degradation of FcR-bound ligands was determined
in separate experiments using immune complexes formed from iodinated
BSA and affinity purified anti-DNP IgG. After each chase time, the ap-
pearance of TCA-soluble 125I in the medium was determined. 
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ble 
 
125
 
I into the medium after uptake of immune com-
plexes containing radioiodinated DNP-BSA and anti-DNP
IgG. We chose to follow the fate of DNP-BSA since the
time course of degradation is known to be more rapid than
that of either the Ig Ag or HRP molecule; OVA could not
be efficiently iodinated. As shown in Fig. 3 
 
B
 
, the degrada-
tion rates of Ag were not affected significantly by rab4 WT
or rab4N
 
121
 
I. Thus, overexpression of either WT or mu-
tant rab4 had little if any effect on the receptor-mediated
uptake or degradation of bound Ag.
Expression of rab4 N121I Selectively Blocks FcR-mediated Ag
Processing. In the absence of any obvious alterations in the
endocytosis or lysosomal delivery of Ag via BCR or FcR,
it seemed likely that the expression of WT or mutant rab4
would similarly have no effect upon Ag processing and pre-
sentation. However, we found that expression of the dom-
inant negative rab4 N121I mutant significantly inhibited the
processing of several different Ags.
We first tested the ability of the transfected A20 cells to
process and present OVA to the DO.11.10 T cell hybrid-
oma. Immune complexes of DNP-OVA and rabbit anti-
DNP IgG (16, 18) were incubated overnight together with
the Ag-specific T cell hybridoma and control B cells (ex-
pressing FcgRII-B2); FcR-expressing B cells transfected
with WT rab4 or rab4N121I; or the FcR-negative IIA1.6 B
cell. As shown in Fig. 4 A, cells overexpressing WT rab4
exhibited processing and presentation activities, as measured
by IL-2 quantities, only slightly lower than control cells
containing solely endogenous rab4. Maximum presentation
was reached at z1  mg/ml OVA. Most interestingly,
rab4N121I-expressing cells were negative for presentation of
the Ag concentrations used (0.1–2 mg/ml), and were al-
most indistinguishable from the parental IIA1.6 cells.
Remarkably, this defect in Ag processing was selective for
receptor-mediated Ag internalization. Rab4N121I-express-
ing cells showed no significant differences in their presenta-
tion capacity when incubated with soluble OVA relative to
control cells or WT rab4 overexpressors (Fig. 4 B). Impor-
tantly, the concentrations of DNP-OVA required for pre-
sentation as soluble Ag were 103-fold higher than that for
FcR-bound DNP-OVA. Similar results were obtained
whether T cell stimulation was monitored using [3H]thy-
midine incorporation or IL-2 release assays (data not
shown). Demonstration that the defect was restricted to Ag
processing, as opposed to Ag presentation, was illustrated
by the observation that addition of a synthetic OVA pep-
tide corresponding to the DO-11.10 epitope (OVA 323–
339; reference 19) produced indistinguishable T cell re-
sponses in all transfected APCs (Fig. 4 C). This result was
consistent with the similar amounts of surface MHC class II
found on all cell lines (Fig. 1 B).
These results were then extended to a second FcR-inter-
nalized Ag. Immune complexes of the cI fragment of l re-
pressor were generated by incubating the Ag together with
two different cI fragment–specific mAbs. Studies have
shown previously that these immune complexes can be
processed and presented to the 24.4 T cell hybridoma (16).
Overexpression of WT rab4 had little effect on the process-
ing and presentation of the cI-containing immune com-
plexes; however, rab4N121I expression almost completely
blocked cI processing (Fig. 5 A). Similar to OVA, the
block seemed to be at the level of Ag processing since all
cell types equally presented the synthetic peptide corre-
sponding to the 24.4 T cell epitope (residues 12–26; Fig.
5 B) as well as the intact cI fragment 1–102 (data not
shown). In the experiments shown, the IL-2 responses
reached for immune-complexed Ag were suboptimal (Fig.
5 A) owing to the variability in T cell hybridoma response,
and are not a reflection of the highest 24.4 T cell response
that we have observed for this Ag.
Figure 4. Expression of
rab4N121I blocks presentation of
Fc receptor-bound DNP-OVA,
but not soluble DNP-OVA or
an immunogenic OVA peptide.
Graphs illustrate the presenta-
tion of increasing concentrations
of DNP-OVA either as an im-
mune complex (A) or free pro-
tein (B) by FcR-negative A20 B
cells transfected with FcgRII-B2
and the indicated rab protein to
the OVA-specific DO-11.10 T
cell hybridoma. Similar condi-
tions were done with immu-
nogenic OVA323-339 peptide
(C). Secreted IL-2 was mea-
sured by ELISA or [3H]thymi-
dine incorporation. Symbols rep-
resent control mock-transfected
for rab4 cells (d), WT rab4 cells
(s), rab4N121I expressors (j),
and the FcR-deficient IIA1.6
cell line (h). Note that the range
of Ag and peptide concentrations
varies by 103-fold in each of the
experiments shown.
Figure 5. Expression of mu-
tant rab4 blocks presentation of
Fc receptor-bound l repressor
but not soluble l represssor.
FcR-negative A20 B cells trans-
fected with FcgRII-B2 and the
indicated rab protein tested for
their presentation to the l re-
pressor-cI fragment-specific 24.4
T cell hybridoma with the cI
fragment as an immune complex
(A) or synthetic peptide (residues
12–26) (B) as in Fig. 3.1773 Lazzarino et al.
Rab4 Is also Required for Presentation of BCR-bound Ag.
Although the Ag specificity of the endogenous BCR in
A20 cells is unknown, the cells can process and present an
epitope found in rabbit IgG after internalization of rabbit
anti–mouse Ig (4). Control, rab4 WT, and rab4N121I-
expressing cells were incubated with various concentrations
of an F(ab9)2 rabbit anti–mouse IgG (0.001–1 mg/ml) and
the 2R.50 T cell hybridoma for 18–24 h and then the su-
pernatants were tested for IL-2. The expression of the
rab4N121I mutant significantly depressed the processing and
presentation of the rabbit IgG epitope (Fig. 6), shifting the
dose–response curve by .10-fold. Since the precise epi-
tope recognized by 2R.50 T cells is unknown, it was not
possible to confirm directly that the defect was limited to
Ag processing as for cI and OVA. However, given the results
obtained for cI and OVA, as well as the observation that nor-
mal rates and quantities of F(ab9)2 rabbit anti–mouse IgG
were internalized and degraded by cells expressing the rab4
mutant, our data strongly suggest that the block in the pre-
sentation of this BCR-bound Ag was at the level of pro-
cessing. Since the A20-cell line can be stimulated to secrete
its own IL-2 through the binding of both monovalent and
divalent Abs to the BCR (20) we confirmed these results
using fixed Ag-fed APCs (data not shown).
The phenotype of the rab4N121I-expressing A20 cells
demonstrates that although endocytosis is necessary for Ag
processing, the mere fact that an Ag is internalized is insuf-
ficient to ensure a functional presentation event. These
cells take up and degrade Ag at normal rates when internal-
ized by either the BCR or by a transfected, endocytosis-
competent FcR. Yet their ability to process at least three
different Ags was dramatically reduced. The defect could
not be explained by an inability of the rab4N121I-expressors
to present Ag, since they were completely capable of stim-
ulating T cells after capturing synthetic immunogenic pep-
tides. Even more remarkably, they remained capable of
processing and presenting the very same Ags if internalized
as fluid phase components, albeit at .103-fold higher con-
centrations.
Discussion
The humoral immune response is dependent critically
on the ability of B cells to present Ags only to those T cells
that share their Ag specificity. Thus, B cells can present Ags
internalized by the BCR .103-fold more efficiently than
Ags internalized nonspecifically by fluid phase endocytosis
(2, 4–6). B cells appear similarly efficient at presenting vir-
tually any Ag if internalized as an immune complex, proba-
bly explaining why B cells normally express an endocyto-
sis-defective splice isoform of FcgRII (10). Our results
suggest that B cells may possess at least one additional fea-
ture that helps ensure the efficiency and, therefore, speci-
ficity of receptor-mediated Ag processing; namely the ex-
istence of a rab4-dependent step that is required for the
presentation of receptor-bound, but not nonspecifically in-
ternalized, Ags.
One or more explanations might account for the ability
of rab4N121I expression to selectively inactivate receptor-
mediated Ag processing. First, it is possible that receptor-
bound and nonspecifically internalized Ags are processed
and loaded onto class II molecules at different sites. Thus,
expression of rab4N121I may prevent delivery of BCR- or
FcR-bound Ags, or the delivery of critical Golgi complex–
derived components (e.g., MHC class II, HLA-DM, pro-
teases), to a specialized site(s) for receptor-mediated Ag
processing. Conceivably, such a site may correspond to the
class II vesicle compartment previously identified in A20
cells (9, 10). Second, rab4N121I may block delivery of Ag
or class II to otherwise conventional endocytic compart-
ments. Third, it is possible that peptide–class II complexes
form normally, but are prevented from being routed to the
plasma membrane by rab4N121I expression. Although these
questions would be best addressed by subcellular fraction-
ation, it has thus far proved impossible to adopt this ap-
proach. Rab4N121I-expression is sufficiently unstable so as
to prevent the propagation of sufficient quantities of ho-
mogeneously expressing cells to permit fractionation ex-
periments.
Much remains to be learned about the intracellular com-
partments responsible for Ag processing and peptide load-
ing. Different compartments may be used by APCs de-
pending upon the cell’s primary mode of Ag delivery and
proteolytic susceptibility, as each organelle is unique in
both pH and enzyme content (1–3). Early processing
events would rapidly generate a repertoire of class II–pep-
tide complexes from those Ags that require minimal pro-
teolysis, perhaps skewing the immune response towards
Ags with characteristically low dependencies on invariant
chain or class II–associated molecules such as HLA-DM
(22, 25). This is likely true for both OVA and l repressor
cI fragment (21, 24). Indeed, delivery of such Ags to later
compartments, richer in proteolytic enzymes, might result
in the loss of such early epitopes due to degradation. Al-
though we have not yet been able to define the precise step
or pathway affected by expression of mutant rab4, our re-
sults demonstrate that the early endosome-recycling path-
way, rather than the late endosome-lysosome pathway,
plays a disproportionately important role in the productive
processing of at least several receptor-bound Ags.
Figure 6. Expression of
rab4N121I blocks presentation of
rabbit IgG bound to endogenous
BCR on A20 cells. A20 cells
were incubated with the indi-
cated concentrations of F(ab9)2
fragments of an affinity-purified
rabbit anti–mouse IgG Ab (Cap-
pel, Durham, NC) together with
the rabbit IgG-specific T cell
hybridoma, 2R.50, under the
conditions described in Fig. 3. Both mock- and WT rab4–transfected B
cells stimulated the T cells at Ag concentrations ,10-fold lower than
rab4N121I-expressing B cells.1774 Antigen Processing and rab4 in A20 B Cells
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